Year |
Citation |
Score |
2023 |
Doshi A, Erickson P, Teryek M, Parekkadan B. Dynamics of Ex Vivo Mesenchymal Stromal Cell Potency under Continuous Perfusion. International Journal of Molecular Sciences. 24. PMID 37298556 DOI: 10.3390/ijms24119602 |
0.368 |
|
2023 |
Teryek M, Jadhav P, Bento R, Parekkadan B. 3D Microcapsules for Human Bone Marrow Derived Mesenchymal Stem Cell Biomanufacturing in a Vertical-Wheel Bioreactor. Biorxiv : the Preprint Server For Biology. PMID 36824906 DOI: 10.1101/2023.02.16.528656 |
0.358 |
|
2021 |
Swaminathan M, Kopyt N, Atta MG, Radhakrishnan J, Umanath K, Nguyen S, O'Rourke B, Allen A, Vaninov N, Tilles A, LaPointe E, Blair A, Gemmiti C, Miller B, Parekkadan B, et al. Pharmacological effects of ex vivo mesenchymal stem cell immunotherapy in patients with acute kidney injury and underlying systemic inflammation. Stem Cells Translational Medicine. PMID 34581517 DOI: 10.1002/sctm.21-0043 |
0.358 |
|
2021 |
O'Rourke B, Nguyen S, Tilles AW, Bynum JA, Cap AP, Parekkadan B, Barcia RN. Mesenchymal stromal cell delivery via an ex vivo bioreactor preclinical test system attenuates clot formation for intravascular application. Stem Cells Translational Medicine. PMID 33527780 DOI: 10.1002/sctm.20-0454 |
0.342 |
|
2020 |
Allen A, Vaninov N, Li M, Nguyen S, Singh M, Igo P, Tilles AW, O'Rourke B, Miller BLK, Parekkadan B, Barcia RN. Author Correction: Mesenchymal Stromal Cell Bioreactor for Ex Vivo Reprogramming of Human Immune Cells. Scientific Reports. 10: 15451. PMID 32943743 DOI: 10.1038/S41598-020-72947-Y |
0.39 |
|
2020 |
Tamayo AG, Shukor S, Burr A, Erickson P, Parekkadan B. Tracking leukemic T-cell transcriptional Dynamics in vivo with a blood-based reporter assay. Febs Open Bio. PMID 32710494 DOI: 10.1002/2211-5463.12940 |
0.414 |
|
2020 |
Allen A, Vaninov N, Li M, Nguyen S, Igo P, Tilles AW, O'Rourke B, Miller BLK, Parekkadan B, Barcia RN. Mesenchymal Stromal Cell Bioreactor for Ex Vivo Reprogramming of Human Immune Cells. Scientific Reports. 10: 10142. PMID 32576889 DOI: 10.1038/S41598-020-67039-W |
0.449 |
|
2020 |
Barcia R, Nguyen S, O'Rourke B, Igo P, Tilles A, Miller B, Parekkadan B. Immune Reprogramming in Human Subjects after Extracorporeal Mesenchymal Stromal Cell Therapy Cytotherapy. 22: S11. DOI: 10.1016/J.Jcyt.2020.03.473 |
0.436 |
|
2019 |
Aijaz A, Trawinski D, McKirgan S, Parekkadan B. Non-invasive cell counting of adherent, suspended and encapsulated mammalian cells using optical density. Biotechniques. PMID 31870165 DOI: 10.2144/Btn-2019-0052 |
0.396 |
|
2019 |
Chin LY, Carroll C, Raigani S, Detelich DM, Tessier SN, Wojtkiewicz GR, Schmidt SP, Weissleder R, Yeh H, Uygun K, Parekkadan B. Ex vivo perfusion-based engraftment of genetically engineered cell sensors into transplantable organs. Plos One. 14: e0225222. PMID 31790444 DOI: 10.1371/Journal.Pone.0225222 |
0.4 |
|
2019 |
Timmins LM, Patel RS, Teryek MS, Parekkadan B. Real-time transfer of lentiviral particles by producer cells using an engineered coculture system. Cytotechnology. PMID 31515650 DOI: 10.1007/S10616-019-00343-0 |
0.367 |
|
2019 |
Burr A, Parekkadan B. Kinetics of MSC-based enzyme therapy for immunoregulation. Journal of Translational Medicine. 17: 263. PMID 31409424 DOI: 10.1186/S12967-019-2000-6 |
0.402 |
|
2019 |
Li M, Chin LY, Shukor S, Tamayo AG, Maus MV, Parekkadan B. Effects of intermittent T-cell cluster disaggregation on proliferative capacity and checkpoint marker expression. Autoimmunity. 1-6. PMID 31238751 DOI: 10.1080/08916934.2019.1630064 |
0.351 |
|
2019 |
Aijaz A, Vaninov N, Allen A, Barcia RN, Parekkadan B. Convergence of Cell Pharmacology and Drug Delivery. Stem Cells Translational Medicine. PMID 31091020 DOI: 10.1002/Sctm.19-0019 |
0.407 |
|
2019 |
Barcia R, Allen A, Vaninov N, Nguyen S, Goodale L, Igo P, Tilles A, Huertas P, Miller B, Parekkadan B. PhaseI/II interim analysis of extracorporeal mesenchymal Stromal cell therapy (SBI-101 Therapy) in subjects with acute kidney injury Cytotherapy. 21: e5. DOI: 10.1016/J.Jcyt.2019.04.016 |
0.411 |
|
2019 |
Allen A, Vaninov N, Nguyen S, Igo P, Tilles A, Parekkadan B, Barcia R. Restoring balance to the immune system via Ex Vivo MSC therapy Cytotherapy. 21: S56. DOI: 10.1016/J.Jcyt.2019.03.428 |
0.481 |
|
2018 |
Aijaz A, Li M, Smith D, Khong D, LeBlon C, Fenton OS, Olabisi RM, Libutti S, Tischfield J, Maus MV, Deans R, Barcia RN, Anderson DG, Ritz J, Preti R, ... Parekkadan B, et al. Biomanufacturing for clinically advanced cell therapies. Nature Biomedical Engineering. 2: 362-376. PMID 31011198 DOI: 10.1038/S41551-018-0246-6 |
0.423 |
|
2018 |
Li M, Chin LY, Shukor S, Tamayo A, Maus MV, Parekkadan B. Closed loop bioreactor system for the ex vivo expansion of human T cells. Cytotherapy. PMID 30497956 DOI: 10.1016/J.Jcyt.2018.10.009 |
0.353 |
|
2018 |
Mukundan S, Sharma K, Honselmann K, Singleton A, Liss A, Parekkadan B. Image-Based Profiling of Patient-Derived Pancreatic Tumor-Stromal Cell Interactions Within a Micropatterned Tumor Model. Technology in Cancer Research & Treatment. 17: 1533033818803632. PMID 30348057 DOI: 10.1177/1533033818803632 |
0.337 |
|
2018 |
Miller BLK, Garg P, Bronstein B, LaPointe E, Lin H, Charytan DM, Tilles AW, Parekkadan B. Extracorporeal Stromal Cell Therapy for Subjects With Dialysis-Dependent Acute Kidney Injury. Kidney International Reports. 3: 1119-1127. PMID 30197978 DOI: 10.1016/J.Ekir.2018.05.009 |
0.381 |
|
2018 |
Knoblich K, Cruz Migoni S, Siew SM, Jinks E, Kaul B, Jeffery HC, Baker AT, Suliman M, Vrzalikova K, Mehenna H, Murray PG, Barone F, Oo YH, Newsome PN, Hirschfield G, ... ... Parekkadan B, et al. The human lymph node microenvironment unilaterally regulates T-cell activation and differentiation. Plos Biology. 16: e2005046. PMID 30180168 DOI: 10.1371/Journal.Pbio.2005046 |
0.381 |
|
2018 |
Li M, Khong D, Chin LY, Singleton A, Parekkadan B. Therapeutic Delivery Specifications Identified Through Compartmental Analysis of a Mesenchymal Stromal Cell-Immune Reaction. Scientific Reports. 8: 6816. PMID 29717209 DOI: 10.1038/S41598-018-24971-2 |
0.451 |
|
2018 |
Khong D, Li M, Singleton A, Chin LY, Parekkadan B. Stromalized microreactor supports murine hematopoietic progenitor enrichment. Biomedical Microdevices. 20: 13. PMID 29353324 DOI: 10.1007/S10544-017-0255-3 |
0.399 |
|
2017 |
Khong D, Li M, Singleton A, Chin LY, Munkundan S, Parekkadan B. Orthogonal Potency Analysis of Mesenchymal Stromal Cell Function During Ex Vivo Expansion. Experimental Cell Research. PMID 29137914 DOI: 10.1016/J.Yexcr.2017.11.007 |
0.469 |
|
2017 |
Singleton A, Khong D, Chin LY, Mukundan S, Li M, Parekkadan B. An engineered biomarker system to monitor and modulate immune clearance of cell therapies. Cytotherapy. PMID 28917628 DOI: 10.1016/J.Jcyt.2017.08.003 |
0.407 |
|
2016 |
Lee J, Heckl D, Parekkadan B. Multiple genetically engineered humanized microenvironments in a single mouse. Biomaterials Research. 20: 19. PMID 27354920 DOI: 10.1186/S40824-016-0066-2 |
0.401 |
|
2016 |
Shen K, Luk S, Elman J, Murray R, Mukundan S, Parekkadan B. Suicide Gene-Engineered Stromal Cells Reveal a Dynamic Regulation of Cancer Metastasis. Scientific Reports. 6: 21239. PMID 26893143 DOI: 10.1038/Srep21239 |
0.34 |
|
2016 |
Parekkadan B. A wealth of cells Science Translational Medicine. 8: 323ec14-323ec14. DOI: 10.1126/Scitranslmed.Aaf0866 |
0.46 |
|
2015 |
Parekkadan B. Press pause to fast forward Science Translational Medicine. 7: 317ec211-317ec211. DOI: 10.1126/Scitranslmed.Aad8030 |
0.383 |
|
2015 |
Parekkadan B. Shining a light on stem cell biology Science Translational Medicine. 7: 299ec133-299ec133. DOI: 10.1126/Scitranslmed.Aac9320 |
0.358 |
|
2015 |
Parekkadan B. It takes two to tango Science Translational Medicine. 7: 287ec77-287ec77. DOI: 10.1126/Scitranslmed.Aab3976 |
0.337 |
|
2015 |
Parekkadan B. 256. Pharmacokinetics of Natural and Engineered Secreted Factors Delivered by a Cell Therapeutic Molecular Therapy. 23: S100-S101. DOI: 10.1016/S1525-0016(16)33861-8 |
0.513 |
|
2014 |
Shen K, Luk S, Hicks DF, Elman JS, Bohr S, Iwamoto Y, Murray R, Pena K, Wang F, Seker E, Weissleder R, Yarmush ML, Toner M, Sgroi D, Parekkadan B. Resolving cancer-stroma interfacial signalling and interventions with micropatterned tumour-stromal assays. Nature Communications. 5: 5662. PMID 25489927 DOI: 10.1038/Ncomms6662 |
0.478 |
|
2014 |
Bersani F, Lee J, Yu M, Morris R, Desai R, Ramaswamy S, Toner M, Haber DA, Parekkadan B. Bioengineered implantable scaffolds as a tool to study stromal-derived factors in metastatic cancer models. Cancer Research. 74: 7229-38. PMID 25339351 DOI: 10.1158/0008-5472.Can-14-1809 |
0.407 |
|
2014 |
Fletcher AL, Elman JS, Astarita J, Murray R, Saeidi N, D'Rozario J, Knoblich K, Brown FD, Schildberg FA, Nieves JM, Heng TS, Boyd RL, Turley SJ, Parekkadan B. Lymph node fibroblastic reticular cell transplants show robust therapeutic efficacy in high-mortality murine sepsis. Science Translational Medicine. 6: 249ra109. PMID 25122637 DOI: 10.1126/Scitranslmed.3009377 |
0.396 |
|
2014 |
Shen K, Lee J, Yarmush ML, Parekkadan B. Microcavity substrates casted from self-assembled microsphere monolayers for spheroid cell culture. Biomedical Microdevices. 16: 609-15. PMID 24781882 DOI: 10.1007/S10544-014-9863-3 |
0.493 |
|
2014 |
Elman JS, Murray RC, Murray RM, Wang F, Shen K, Gao S, Conway KE, Yarmush ML, Tannous BA, Weissleder R, Parekkadan B. Pharmacokinetics of natural and engineered secreted factors delivered by mesenchymal stromal cells. Plos One. 9: e89882. PMID 24587097 DOI: 10.1371/Journal.Pone.0089882 |
0.627 |
|
2014 |
Milwid JM, Elman JS, Li M, Shen K, Manrai A, Gabow A, Yarmush J, Jiao Y, Fletcher A, Lee J, Cima MJ, Yarmush ML, Parekkadan B. Enriched protein screening of human bone marrow mesenchymal stromal cell secretions reveals MFAP5 and PENK as novel IL-10 modulators. Molecular Therapy : the Journal of the American Society of Gene Therapy. 22: 999-1007. PMID 24496384 DOI: 10.1038/Mt.2014.17 |
0.772 |
|
2014 |
Elman JS, Li M, Wang F, Gimble JM, Parekkadan B. A comparison of adipose and bone marrow-derived mesenchymal stromal cell secreted factors in the treatment of systemic inflammation. Journal of Inflammation (London, England). 11: 1. PMID 24397734 DOI: 10.1186/1476-9255-11-1 |
0.499 |
|
2014 |
Patel SJ, Milwid JM, King KR, Bohr S, Iracheta-Velle A, Li M, Vitalo A, Parekkadan B, Jindal R, Yarmush ML. Erratum: Gap junction inhibition prevents drug-induced liver toxicity and fulminant hepatic failure Nature Biotechnology. 32: 291-291. DOI: 10.1038/nbt0314-291c |
0.715 |
|
2013 |
Lee J, Wang JB, Bersani F, Parekkadan B. Capture and printing of fixed stromal cell membranes for bioactive display on PDMS surfaces. Langmuir : the Acs Journal of Surfaces and Colloids. 29: 10611-6. PMID 23927769 DOI: 10.1021/La4012795 |
0.339 |
|
2012 |
Milwid JM, Ichimura T, Li M, Jiao Y, Lee J, Yarmush JS, Parekkadan B, Tilles AW, Bonventre JV, Yarmush ML. Secreted factors from bone marrow stromal cells upregulate IL-10 and reverse acute kidney injury. Stem Cells International. 2012: 392050. PMID 23319959 DOI: 10.1155/2012/392050 |
0.775 |
|
2012 |
Lee J, Li M, Milwid J, Dunham J, Vinegoni C, Gorbatov R, Iwamoto Y, Wang F, Shen K, Hatfield K, Enger M, Shafiee S, McCormack E, Ebert BL, Weissleder R, ... ... Parekkadan B, et al. Implantable microenvironments to attract hematopoietic stem/cancer cells. Proceedings of the National Academy of Sciences of the United States of America. 109: 19638-43. PMID 23150542 DOI: 10.1073/Pnas.1208384109 |
0.774 |
|
2012 |
Patel SJ, Milwid JM, King KR, Bohr S, Iracheta-Vellve A, Iracheta-Velle A, Li M, Vitalo A, Parekkadan B, Jindal R, Yarmush ML. Gap junction inhibition prevents drug-induced liver toxicity and fulminant hepatic failure. Nature Biotechnology. 30: 179-83. PMID 22252509 DOI: 10.1038/Nbt.2089 |
0.72 |
|
2012 |
Parekkadan B, Fletcher AL, Li M, Tjota MY, Bellemare-Pelletier A, Milwid JM, Lee JW, Yarmush ML, Turley SJ. Aire controls mesenchymal stem cell-mediated suppression in chronic colitis. Molecular Therapy : the Journal of the American Society of Gene Therapy. 20: 178-86. PMID 21952165 DOI: 10.1038/Mt.2011.192 |
0.773 |
|
2012 |
Li M, Tilles AW, Milwid JM, Hammad M, Lee J, Yarmush ML, Parekkadan B. Phenotypic and functional characterization of human bone marrow stromal cells in hollow-fibre bioreactors. Journal of Tissue Engineering and Regenerative Medicine. 6: 369-77. PMID 21710576 DOI: 10.1002/Term.439 |
0.781 |
|
2011 |
Parekkadan B, Upadhyay R, Dunham J, Iwamoto Y, Mizoguchi E, Mizoguchi A, Weissleder R, Yarmush ML. Bone marrow stromal cell transplants prevent experimental enterocolitis and require host CD11b+ splenocytes. Gastroenterology. 140: 966-75. PMID 20955701 DOI: 10.1053/J.Gastro.2010.10.013 |
0.616 |
|
2011 |
Jiao J, Milwid JM, Yarmush ML, Parekkadan B. A mesenchymal stem cell potency assay. Methods in Molecular Biology (Clifton, N.J.). 677: 221-31. PMID 20941614 DOI: 10.1007/978-1-60761-869-0_16 |
0.79 |
|
2010 |
Yagi H, Soto-Gutierrez A, Navarro-Alvarez N, Nahmias Y, Goldwasser Y, Kitagawa Y, Tilles AW, Tompkins RG, Parekkadan B, Yarmush ML. Reactive bone marrow stromal cells attenuate systemic inflammation via sTNFR1. Molecular Therapy : the Journal of the American Society of Gene Therapy. 18: 1857-64. PMID 20664529 DOI: 10.1038/Mt.2010.155 |
0.77 |
|
2010 |
Yagi H, Soto-Gutierrez A, Parekkadan B, Kitagawa Y, Tompkins RG, Kobayashi N, Yarmush ML. Mesenchymal stem cells: Mechanisms of immunomodulation and homing. Cell Transplantation. 19: 667-79. PMID 20525442 DOI: 10.3727/096368910X508762 |
0.604 |
|
2010 |
Parekkadan B, Milwid JM. Mesenchymal stem cells as therapeutics. Annual Review of Biomedical Engineering. 12: 87-117. PMID 20415588 DOI: 10.1146/Annurev-Bioeng-070909-105309 |
0.79 |
|
2009 |
Yagi H, Parekkadan B, Suganuma K, Soto-Gutierrez A, Tompkins RG, Tilles AW, Yarmush ML. Long-term superior performance of a stem cell/hepatocyte device for the treatment of acute liver failure. Tissue Engineering. Part A. 15: 3377-88. PMID 19397469 DOI: 10.1089/Ten.Tea.2008.0681 |
0.614 |
|
2008 |
Parekkadan B, Berdichevsky Y, Irimia D, Leeder A, Yarmush G, Toner M, Levine JB, Yarmush ML. Cell-cell interaction modulates neuroectodermal specification of embryonic stem cells. Neuroscience Letters. 438: 190-5. PMID 18467031 DOI: 10.1016/J.Neulet.2008.03.094 |
0.584 |
|
2008 |
Parekkadan B, Tilles AW, Yarmush ML. Bone marrow-derived mesenchymal stem cells ameliorate autoimmune enteropathy independently of regulatory T cells Stem Cells. 26: 1913-1919. PMID 18420833 DOI: 10.1634/Stemcells.2007-0790 |
0.602 |
|
2008 |
van Poll D, Parekkadan B, Cho CH, Berthiaume F, Nahmias Y, Tilles AW, Yarmush ML. Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo. Hepatology (Baltimore, Md.). 47: 1634-43. PMID 18395843 DOI: 10.1002/Hep.22236 |
0.604 |
|
2008 |
Levine JB, Leeder AD, Parekkadan B, Berdichevsky Y, Rauch SL, Smoller JW, Konradi C, Berthiaume F, Yarmush ML. Isolation rearing impairs wound healing and is associated with increased locomotion and decreased immediate early gene expression in the medial prefrontal cortex of juvenile rats. Neuroscience. 151: 589-603. PMID 18063315 DOI: 10.1016/J.Neuroscience.2007.10.014 |
0.419 |
|
2008 |
van Poll D, Parekkadan B, Borel Rinkes IHM, Tilles AW, Yarmush ML. Mesenchymal Stem Cell Therapy for Protection and Repair of Injured Vital Organs Cellular and Molecular Bioengineering. 1: 42-50. DOI: 10.1007/S12195-008-0001-2 |
0.603 |
|
2007 |
Parekkadan B, van Poll D, Suganuma K, Carter EA, Berthiaume F, Tilles AW, Yarmush ML. Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure. Plos One. 2: e941. PMID 17895982 DOI: 10.1371/Journal.Pone.0000941 |
0.628 |
|
2007 |
Parekkadan B, van Poll D, Megeed Z, Kobayashi N, Tilles AW, Berthiaume F, Yarmush ML. Immunomodulation of activated hepatic stellate cells by mesenchymal stem cells. Biochemical and Biophysical Research Communications. 363: 247-52. PMID 17869217 DOI: 10.1016/J.Bbrc.2007.05.150 |
0.613 |
|
2007 |
Parekkadan B, Sethu P, van Poll D, Yarmush ML, Toner M. Osmotic selection of human mesenchymal stem/progenitor cells from umbilical cord blood. Tissue Engineering. 13: 2465-73. PMID 17665999 DOI: 10.1089/Ten.2007.0054 |
0.55 |
|
Show low-probability matches. |